ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

263
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
05 Nov 2023 10:10

A-H Premium Weekly (Nov 3rd): Ganfeng Lithium, CMS, Wuxi Apptec

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Ganfeng Lithium, China Merchant Securities and Wuapptec.

Logo
462 Views
Share
05 Nov 2023 10:05

HK Short Interest Weekly: Yankuang Energy, CCB, Bidu, Petrochina

We analyzed the latest HK SFC report for aggregate short position as of Oct 27th and highlight short interest changes in Yankuang Energy, CCB,...

Logo
490 Views
Share
bullishWuxi Biologics
05 Nov 2023 08:25

ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
410 Views
Share
bearishWuXi AppTec
02 Nov 2023 08:55

WuXi AppTec (2359.HK/603259.CH) 23Q3 - Will the TIDES Business Turn the Tide?

WuXi AppTec received Lilly's GLP-1 order, but it's too small to guarantee the reversal logic.23Q3 results sounded an alarm for investors.The savior...

Logo
507 Views
Share
bullishWuXi AppTec
01 Nov 2023 18:52Broker

WuXi AppTec (603259 CH) – Peptide Business Becoming a New Growth Driver

WuXi AppTec reported 3Q23 revenue of RMB10,670mn, up 0.3% YoY, and attributable recurring net income of RMB2,948mn, up 23.8% YoY

Logo
210 Views
Share
x